Diseases, Conditions, Syndromes

Arthritis drug presents promise as treatment for COVID-19 pneumonia

UC San Diego Health has launched a Phase III clinical trial, part of a global effort, to assess whether a medication used to treat rheumatoid arthritis and other inflammatory disorders might also have therapeutic value for ...


Tocilizumab cuts progression to ventilation or death in COVID-19

(HealthDay)—Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study published online Dec. 18 in the New England Journal of Medicine.

page 1 from 3